Elevated LDH predicts poor outcome of recurrent germ cell tumours treated with dose dense chemotherapy

European Journal of Cancer

Volumn 46, Issue 16, 2010, Pages 2913-2918

  Gerlinger, Marco ^a   Wilson, Peter ^a   Powles, Thomas ^a   Shamash, Jonathan ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Dose dense chemotherapy; Lactate dehydrogenase; Prognostic factors; Recurrent germ cell tumours; Salvage chemotherapy

Indexed keywords

BLEOMYCIN; CISPLATIN; DACTINOMYCIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; LACTATE DEHYDROGENASE; METHOTREXATE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SEMINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR RECURRENCE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; GENITAL NEOPLASMS, MALE; HUMANS; KAPLAN-MEIER ESTIMATE; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; SALVAGE THERAPY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 78049299508     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2010.07.004     Document Type: Article

References (9)

1. R.J. Motzer, N.L. Geller, and C.C. Tan Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center Experience (1979-1989) Cancer 67 5 1991 1305 1310
2. G.V. Kondagunta, J. Bacik, and A. Donadio Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors J Clin Oncol 23 27 2005 6549 6555
3. S.D. Fossa, S.P. Stenning, and A. Gerl Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours Brit J Cancer 80 9 1999 1392 1399
4. J. Shamash, R.T. Oliver, and J. Ong Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy Ann Oncol 10 6 1999 685 692
5. J. Shamash, T. Powles, and W. Ansell GAMEC - a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours Brit J Cancer 97 3 2007 308 314
6. J. Beyer, A. Kramar, and R. Mandanas High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables J Clin Oncol 14 10 1996 2638 2645 (Pubitemid 26329647)
7. J.T. Hartmann, L. Einhorn, and C.R. Nichols Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis J Clin Oncol 19 6 2001 1641 1648
8. K.D. Miller, P.J. Loehrer, R. Gonin, and L.H. Einhorn Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma J Clin Oncol 15 4 1997 1427 1431
9. J. Vuky, S.K. Tickoo, and J. Sheinfeld Salvage chemotherapy for patients with advanced pure seminoma J Clin Oncol 20 1 2002 297 301